Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and six months ended June 30, 2014, and provided an operating forecast and program updates.
Financial highlights for the second quarter of 2014 include (all comparisons are with the second quarter of 2013):
•Total revenues increased 11% to $10.6 million, and royalty revenues increased 7% to $5.2 million
Help employers find you! Check out all the jobs and post your resume.
